Offer - Urjas Oil for just ₹ 1 X
Olmezest Beta 50 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Olmezest Beta 50 Tablet also has some secondary and off-label uses. These are listed below.
The right dosage of Olmezest Beta 50 Tablet depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
The most common side effects of Olmezest Beta 50 Tablet are Upper respiratory tract infection, Slow heart rate (pulse). Some other side effects of Olmezest Beta 50 Tablet have been listed ahead. These side effects of Olmezest Beta 50 Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Olmezest Beta 50 Tablet is Severe for pregnant women and Mild for women who are breastfeeding. It is important to know if Olmezest Beta 50 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Olmezest Beta 50 Tablet related warnings section.
Olmezest Beta 50 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Bradycardia (Slow Heart Rate) are examples of such conditions. Other conditions have been mentioned below in the Olmezest Beta 50 Tablet contraindications section.
Additionally, Olmezest Beta 50 Tablet may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Olmezest Beta 50 Tablet is not safe while driving, and is is not addictive in nature.
Olmezest Beta 50 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmezest Beta 50 Tablet safe for pregnant women?
Olmezest Beta shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Olmezest Beta 50 Tablet safe during breastfeeding?
Olmezest Beta has been seen to have minimal side effects on breastfeeding women.
What is the effect of Olmezest Beta 50 Tablet on the Kidneys?
Olmezest Beta is completely safe for kidneys.
What is the effect of Olmezest Beta 50 Tablet on the Liver?
Side effects of Olmezest Beta rarely affect the liver.
What is the effect of Olmezest Beta 50 Tablet on the Heart?
Olmezest Beta may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Olmezest Beta 50 Tablet unless your doctor advises you to do so -
Is this Olmezest Beta 50 Tablet habit forming or addictive?
No, there is no any evidence that Olmezest Beta 50 Tablet is addictive.
Interaction between Food and Olmezest Beta 50 Tablet
Taking Olmezest Beta 50 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Olmezest Beta 50 Tablet
Consumption of alcohol and Olmezest Beta 50 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850